(PDEX) Pro-Dex - Ratings and Ratios

Pro-Dex, Inc. (NASDAQ:PDEX) is a leading developer and manufacturer of powered surgical instruments, primarily serving medical device original equipment manufacturers (OEMs) globally. The company specializes in autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers, which are extensively used in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Additionally, Pro-Dex offers engineering, quality, and regulatory consulting services, leveraging its expertise to support clients in navigating complex technical and compliance challenges. The company also manufactures and sells rotary air motors, known for their high efficiency and durability, catering to various industries beyond healthcare, including high-tech manufacturing. Pro-Dexs products are integral to operations in hospitals, medical engineering laboratories, scientific research facilities, and advanced manufacturing environments. Founded in 1978 and headquartered in Irvine, California, Pro-Dex has established itself as a trusted partner in precision-engineered solutions. Web URL: https://www.pro-dex.com

Based on the provided and , the 3-month forecast for Pro-Dex, Inc. (NASDAQ:PDEX) suggests the following trends: The stock is currently trading at 34.32, slightly above its 20-day simple moving average (SMA) of 34.16 but below its 50-day SMA of 40.93. The 200-day SMA stands at 31.04, indicating potential long-term upward momentum. The Average True Range (ATR) of 2.91 suggests moderate volatility. From a fundamental perspective, the companys market cap of 104.35M USD, P/E ratio of 16.33, and return on equity (RoE) of 21.21 highlight a balance between valuation and profitability. Over the next three months, the stock is expected to range between 31.04 and 40.93, with potential upside driven by strong earnings and continued demand for its surgical instruments. However, downside risks include broader market volatility and competition in the medical device sector.